Trial intelligence / Profile preview

Plasma-Lyte versus 0.9% sodium chloride during deceased-donor kidney transplantation

RBR-9t7r5pPhase 4Completed

Sponsor
Universidade Estadual Paulista
Start
Jul 2017
Modality
Small Molecules
Countries
1
01

Overview

Phase 4, randomised, open-label trial in chronic kidney disease (CKD) comparing Plasma-Lyte intraoperative infusion with 0.9% sodium chloride intraoperative infusion (2 arms). Started Jul 2017; status: completed.

02

Drugs

plasma-lytesodium chloride
03

Conditions

chronic kidney disease (CKD)

Beyond the preview

Go deeper on RBR-9t7r5p.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on RBR-9t7r5p.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call